Yahoo Web Search

Search results

    • Ozempic Patients Need an Off-Ramp

      The Atlantic· 5 days ago

      To pharmaceutical companies selling the blockbuster drugs—known collectively as GLP-1 drugs, after the natural hormone they mimic—that might be a pretty good proposition. GLP-1 drugs do work ...

    • 3 High-Flying Stocks That Could Soar Even More

      3 High-Flying Stocks That Could Soar Even More

      Motley Fool via Yahoo Finance· 3 days ago

      Participants in an early-stage trial taking the pill daily lost an average of 13% of their body weight after just 12 weeks. A phase 2 trial is planned...

    • 2 Stocks That Could 10x by 2035

      2 Stocks That Could 10x by 2035

      Motley Fool via Yahoo Finance· 4 days ago

      Its leading asset is VK2735, and the only medicine on the market of this kind is Eli Lilly's weight-loss treatment Zepbound. In a phase ...

    • Where Will Viking Therapeutics Be in 5 Years?

      Where Will Viking Therapeutics Be in 5 Years?

      Motley Fool via Yahoo Finance· 3 days ago

      Those are early results, but the key thing is that the pill is safe and well-tolerated as well. The company plans to launch a phase 2 ...